RecallDepth
Class II Ongoing

Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Manufactured by: Aurobindo Pharma Limited, Hyderabad-500 090, India, For BluePoint Laboratories NDC 68001-414-04

This recall is currently active, issued January 1, 2025. It was issued by Amerisource Health Services Llc.

Company
Amerisource Health Services Llc
Recall Initiated
December 6, 2024
Posted
January 1, 2025
Recall Number
D-0155-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
21,262 bottles
Firm Location
Columbus, OH, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit.

Distribution

Nationwide in the USA

Lot / Code Info

Lot DT3023029A Exp 02/28/2025

More recalls by Amerisource Health Services Llc

View all recalls by this company →

Other recent Class II Drug recalls